Is KB Financial Group (KB) Stock Undervalued Right Now? — Positive
KB Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Integer (ITGR) is a Top Value Stock for the Long-Term — Positive
ITGR Zacks Investment Research — July 29, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is The Bank of New York Mellon (BK) Stock Outpacing Its Finance Peers This Year? — Positive
BK Zacks Investment Research — July 29, 2025Here is how The Bank of New York Mellon Corporation (BK) and IREN Limited (IREN) have performed compared to their sector so far this year.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term — Positive
LH Zacks Investment Research — July 29, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Investors Undervaluing Gerdau (GGB) Right Now? — Positive
GGB Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Medical Stocks Lagging McKesson (MCK) This Year? — Negative
MCK Zacks Investment Research — July 29, 2025Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Why ArcelorMittal (MT) is a Top Value Stock for the Long-Term — Positive
MT Zacks Investment Research — July 29, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Covenant Logistics Group (CVLG) Stock? — Positive
CVLG Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Auto-Tires-Trucks Stocks Lagging PHINIA Inc. (PHIN) This Year? — Negative
PHIN Zacks Investment Research — July 29, 2025Here is how Phinia (PHIN) and QuantumScape Corporation (QS) have performed compared to their sector so far this year.
Are Investors Undervaluing Vermilion Energy (VET) Right Now? — Positive
VET Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Metalla Royalty & Streaming (MTA) Stock Outpacing Its Basic Materials Peers This Year? — Positive
MTA Zacks Investment Research — July 29, 2025Here is how Metalla Royalty & Streaming Ltd. (MTA) and McEwen (MUX) have performed compared to their sector so far this year.
Are Consumer Discretionary Stocks Lagging Betterware de Mexico SAPI de C (BWMX) This Year? — Negative
BWMX Zacks Investment Research — July 29, 2025Here is how Betterware de Mexico SAPI de C (BWMX) and Laureate Education (LAUR) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Shoe Carnival (SCVL) Right Now? — Positive
SCVL Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing MediaAlpha (MAX) Right Now? — Positive
MAX Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Monro Muffler Brake (MNRO) Stock? — Positive
MNRO Zacks Investment Research — July 29, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Maplebear Inc. (CART) Stock Outpacing Its Retail-Wholesale Peers This Year? — Positive
CART Zacks Investment Research — July 29, 2025Here is how Maplebear (CART) and Groupon (GRPN) have performed compared to their sector so far this year.
Considering ways to update your tech allocation? Technology companies remain a key part of investors' equities portfolios, but challenges continue to loom.
UNH Continues 50% Y/Y Slide, SPOT Sells Off, WHR "Tariff Exposed Story" — Negative
SPOT UNH WHR Schwab Network — July 29, 2025It's all down arrows on this morning's earnings movers. Sam Vadas talks about the "tariff exposed story" impacting Whirlpool (WHR) and UPS Inc. (UPS).
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics — Neutral
SRPT PRNewsWire — July 29, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sarepta To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Sarepta between June 22, 2023 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sarepta Therapeutics, Inc. ("Sarepta" …
